Svetlana Lucas - 18 Jun 2024 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Director
Signature
/s/ Herb Cross, as Attorney-in-Fact
Issuer symbol
JSPR
Transactions as of
18 Jun 2024
Net transactions value
$0
Form type
4
Filing time
20 Jun 2024, 06:07:48 UTC
Previous filing
23 May 2024
Next filing
02 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Stock Option (right to buy) Award $0 +15,000 $0.000000 15,000 18 Jun 2024 Voting Common Stock 15,000 $23.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on June 18, 2025, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.